ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Kite Pharma, Inc.

Kite Pharma, Inc. (KITE)

179.79
0.00
(0.00%)
Closed February 08 4:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
179.79
Bid
107.00
Ask
179.99
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
179.79
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

KITE Latest News

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a wholly-owned subsidiary of Gilead (“Purchaser”...

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of the tender offer by its wholly-owned subsidiary, Dodgers Merger Sub, Inc. (“Purchaser”), for all of the...

Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period

Gilead Sciences, Inc. (Nasdaq: GILD) and Kite Pharma, Inc. (Nasdaq: KITE) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE PR Newswire NEW YORK, Aug. 31, 2017 NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan...

FDA Approves First Gene Therapy in U.S. -- Update

By Austen Hufford The Food and Drug Administration has approved the first gene therapy in the U.S., a long-heralded move for a promising method to combat cancer. The FDA said Wednesday it approved...

FDA Approves First Gene Therapy in U.S.

By Austen Hufford The Food and Drug Administration has approved the first gene therapy in the U.S., a long-heralded move for a promising new method of combating cancer. The FDA said Wednesday it...

Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc.

Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc. PR Newswire NEW YORK, Aug. 29, 2017 NEW YORK, Aug. 29, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating...

What's News: Business & Finance -- WSJ

This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (August 29, 2017). Gilead Sciences...

Gilead to Buy Kite Pharma for Roughly $11 Billion -- 2nd Update

By Jonathan D. Rockoff and Denise Roland Gilead Sciences Inc. on Monday agreed to pay about $11 billion for Kite Pharma Inc., an ambitious bet on a new type of cancer therapy that is on the brink...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

KITE - Frequently Asked Questions (FAQ)

What is the current KITE PHARMA, INC. share price?
The current share price of KITE PHARMA, INC. is $ 179.79
What is the 1 year trading range for KITE PHARMA, INC. share price?
KITE PHARMA, INC. has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
$ 0.4191
(126.54%)
816.59M
CDTConduit Pharmaceuticals Inc
$ 2.831
(82.65%)
144.17M
GSIWGarden Stage Ltd
$ 0.79
(78.73%)
219.64M
TOIIWOncology Institute Inc
$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
$ 1.19
(54.55%)
84.73M
FTELFitell Corporation
$ 2.70
(-57.01%)
2.28M
SGBXSafe and Green Holdings Corporation
$ 0.6401
(-44.82%)
5.15M
NKLANikola Corporation
$ 0.4432
(-41.10%)
47.43M
PLRXPliant Therapeutics Inc
$ 7.785
(-34.85%)
6.4M
LIPOLipella Pharmaceuticals Inc
$ 3.08
(-33.76%)
2.08M
MGOLMGO Global Inc
$ 0.4191
(126.54%)
780.46M
RIMEAlgorhythm Holdings Inc
$ 0.0169
(-20.66%)
262.79M
GSIWGarden Stage Ltd
$ 0.79
(78.73%)
215.16M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0537
(14.74%)
210.78M
NVDANVIDIA Corporation
$ 129.84
(0.90%)
209.04M

Discussion

View Full Feed
sylvia07 sylvia07 4 minutes ago
I will let you do that because you will make up a good lie for them!
DBMM
tedpeele tedpeele 5 minutes ago
The $5.2m shows GP is most accurate about the company.

The move to NASDAQ was not justified, but it was absolutely taken advantage of by the company and its directors at the expense of naive shareholders

That’s the story of lightwave logic. It isn’t an up-and-coming c
LWLG
Green Leaf Smoker Green Leaf Smoker 5 minutes ago
??? Not when someone does the real math, as Volume to SP $ux's on this play MJNA
MJNA
nwsun nwsun 6 minutes ago
I haven't owned intv shares since early 2021. The current malaise has no effect on me. But in a more general observation, the whole penny stock market has under performed since the blowout season of 2020/2021. It's not the same.
INTV
Jack_Bolander Jack_Bolander 6 minutes ago
Banger - Congrats on your 25% Gain... Impressive.

You had sub-$2.00 PLUG stock and you didn't dump at $70 ? $50 ? $20 ? $10 ?

Smart that you sold when you did ... BEFORE the Earnings and Secondary.
PLUG
mrMadMax mrMadMax 6 minutes ago
👊bb96 is right; you ask questions, then ignore the correct answers and continue with your ignorance.

Honestly, it's just as I thought; you can't provide any response to what is a verifiable fact-check. You're a simpleton; even when you're wrong or don't know how to respond, yo
ATMH
Hummingbird2 Hummingbird2 6 minutes ago
Hopefully, more good news on the way soon.
VDRM
misterfishman misterfishman 9 minutes ago
Yes that was a surprise indeed......we desperately need news next week to hold these gains.
IGPK
LVerstee LVerstee 9 minutes ago
You all deserve eachother.
ITUP
Hummingbird2 Hummingbird2 9 minutes ago
🛫 $VDRM 🛫
VDRM
rainmaker71 rainmaker71 9 minutes ago
HUMMINGBIRD MIGHT YOU HAVE ANY INSIGHT FOR THE BOARD?
VDRM
Green Leaf Smoker Green Leaf Smoker 10 minutes ago
Thank u for sharing your validity & investment value to the Phil board
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175778164
PHIL
weedtrader420 weedtrader420 10 minutes ago
BITCOIN PLTR XRP Dream team is in the house.🖕😮‍💨🖕🦨🌳 🐋🌎🚀
PLTR
Polymer Paul Polymer Paul 10 minutes ago
Licence agreements like last time with polariton... Market doesn't give a monkeys about these crumby deals.... There's an old English saying..... Pissing in the wind!
LWLG
Hummingbird2 Hummingbird2 11 minutes ago
🙋

$VDRM
VDRM
glenn1919 glenn1919 11 minutes ago
APPS.....................https://stockcharts.com/h-sc/ui?s=APPS&p=W&b=5&g=0&id=p86431144783
APPS
8lang 8lang 12 minutes ago
4527 02/07/2025***SELECTED PARTIES***DECLARATION of William Christopher Carmody in Opposition re: [4164] JOINT MOTION for Summary Judgment on "Upstream" Issues. Document filed by Mayor and City Council of Baltimore, City of New Britain, Jennie Stuart Medical Center, Inc., Vistra Energy Corp., Yale
glenn1919 glenn1919 13 minutes ago
LAES...............................https://stockcharts.com/h-sc/ui?s=LAES&p=W&b=5&g=0&id=p86431144783
LAES
janetcanada janetcanada 14 minutes ago
🐞***RDAR- Link to the trades:.....
***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-RDAR/trades

🐞***From Barchart.....
***https://www.barchart.com/stocks/quotes/RDAR/overview
RDAR
RealDutch RealDutch 14 minutes ago
Ofcourse Laxmi bought him?

Why do you always have to talk nonsense like this? Dennis has a very senior role within the company. So surely he is entitled to proper compensation.
ITUP
dewophile dewophile 15 minutes ago
not sure how that would translate to later than usual quarter release

They have to decide how and when to prune the spend. Whether or not to stop clinical trials or see HR through. Don't forget the SHionogi data is very recent, so they may have wanted to see that data before finalizin
ENTA
dewophile dewophile 17 minutes ago
I agree w DD that this is a distinct possibility
You do make a point that usually if the company is ready to be sold they get interest ideally from multiple parties who then submit best and final and you don't go the "strategic alternatives" route.
So while you may not have that level
ENTA
Wolf-man jack Wolf-man jack 17 minutes ago
WQLF Conversion Analysis Continued

The 3:1 conversion proposal on September 22, 2023.

https://www.sec.gov/Archives/edgar/data/1644903/000143774923026702/ycbd20230922_defa14a.htm

“ “In the event the Series A Amendment is approved, holders of the Series A P
CVSI YCBD

Your Recent History

Delayed Upgrade Clock